Your browser doesn't support javascript.
loading
Estimating the Period Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During the Omicron (BA.1) Surge in New York City (NYC), 1 January to 16 March 2022.
Qasmieh, Saba A; Robertson, McKaylee M; Teasdale, Chloe A; Kulkarni, Sarah G; Nash, Denis.
Afiliação
  • Qasmieh SA; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, New York, USA.
  • Robertson MM; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, New York, USA.
  • Teasdale CA; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, New York, USA.
  • Kulkarni SG; Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, New York, USA.
  • Nash D; Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York, New York, USA.
Clin Infect Dis ; 76(3): e499-e502, 2023 02 08.
Article em En | MEDLINE | ID: mdl-35959571
ABSTRACT
In a population-based survey of adults in New York City, we assessed positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests (including via exclusive at-home testing) and possible cases among untested respondents. An estimated 27.4% (95% confidence interval [CI] 22.8%-32.0%) or 1.8 million adults (95% CI 1.6-2.1 million) had SARS-CoV-2 infection between 1 January and 16 March 2022.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article